Clinical Trials Browser

Withdrawn × pembrolizumab × Tumor-Agnostic × Clear all

NCT06395090 2025-04-08

MK-9999-01B

Phase 1/2 Withdrawn

Neoplasm Metastasis

NCT03832673 2021-02-26

PECULIAR

Phase 2 Withdrawn

Neoplasms